We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

Back to rankings

58 hedge funds and large institutions have $215M invested in Syneron Medical Ltd in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

467% more call options, than puts

Call options by funds: $17K | Put options by funds: $3K

25% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 16

1% less capital invested

Capital invested by funds: $218M → $215M (-$2.45M)

6% less funds holding

Funds holding: 62 → 58 (-4)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
58
Holders Change
-4
Holders Change %
-6.45%
% of All Funds
1.88%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
20
Reduced
16
Closed
8
Calls
$17K
Puts
$3K
Net Calls
+$14K
Net Calls Change
-$32K

Top Buyers

Rank Fund Capital Flow
1
NTC
North Tide Capital
Massachusetts
+$5.61M
2
CII
CR Intrinsic Investors
Connecticut
+$2.33M
3
BIP
Brandes Investment Partners
California
+$1.96M
4
Deutsche Bank
Deutsche Bank
Germany
+$852K
5
VAM
Visium Asset Management
New York
+$561K

Top Sellers

Rank Fund Capital Flow
1
PCMI
Paradigm Capital Management Inc
New York
-$3.6M
2
FCM
Frontier Capital Management
Massachusetts
-$1.81M
3
SAM
Steinberg Asset Management
New York
-$1.48M
4
BIM
Bogle Investment Management
Massachusetts
-$876K
5
EIM
Essex Investment Management
Massachusetts
-$674K
Name Holding Trade Value Shares
Change 		Change in
Stake
PIM
26
Platinum Investment Management
Australia
$813K – – –
Bank of New York Mellon
27
Bank of New York Mellon
New York
$809K +$150K +17,433 +23%
DCM
28
DAFNA Capital Management
California
$784K – – –
IAM
29
Iridian Asset Management
Connecticut
$439K +$82.3K +9,530 +23%
PPA
30
Parametric Portfolio Associates
Washington
$425K +$39.6K +4,587 +10%
Citadel Advisors
31
Citadel Advisors
Florida
$308K -$580K -67,162 -65%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$298K +$87.2K +10,100 +41%
DC
33
Davenport & Co
Virginia
$285K +$24.3K +2,817 +9%
Two Sigma Advisers
34
Two Sigma Advisers
New York
$236K -$52.6K -6,100 -18%
GI
35
GAMCO Investors
Connecticut
$207K – – –
ARTA
36
A.R.T. Advisors
New York
$164K -$115K -13,300 -41%
Nomura Holdings
37
Nomura Holdings
Japan
$155K -$45.1K -5,227 -23%
EGA
38
Eagle Global Advisors
Texas
$147K – – –
BIM
39
Bogle Investment Management
Massachusetts
$146K -$876K -101,509 -86%
WA
40
Whitebox Advisors
Minnesota
$141K +$141K +16,352 New
GF
41
Gabelli Funds
New York
$121K – – –
Two Sigma Investments
42
Two Sigma Investments
New York
$103K -$468K -54,200 -82%
Invesco
43
Invesco
Georgia
$99K +$10.6K +1,224 +12%
FMT
44
First Mercantile Trust
Tennessee
$89K -$75.3K -8,730 -46%
KIA
45
King Investment Advisors
Texas
$86K +$86.3K +10,000 New
Acadian Asset Management
46
Acadian Asset Management
Massachusetts
$79K – – –
Bank of America
47
Bank of America
North Carolina
$71K -$38.4K -4,445 -35%
Wells Fargo
48
Wells Fargo
California
$56K +$9 +1 +0%
U
49
UBS
Switzerland
$43K +$863 +100 +2%
PFO
50
Pathstone Family Office
New Jersey
$34K – – –
1
2
3

ELOS Hedge Fund Activity: Q3 2013 in Review

58 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q3 2013, worth a combined $215M — down 1.1% from $218M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ELOS and 4 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 20 added.

The largest buyer was North Tide Capital, adding an estimated $5.61M. The largest seller was Paradigm Capital Management Inc, cutting an estimated $3.6M.

  • 58 institutional investors held Syneron Medical Ltd (ELOS) as of Q3 2013, down from 62 in Q2 2013.
  • Funds reported $215M of Syneron Medical Ltd stock for Q3 2013, down 1.1% quarter-over-quarter.
  • 4 funds opened new Syneron Medical Ltd positions in Q3 2013 and 8 closed out, a net change of -4 holders.
  • The largest Syneron Medical Ltd buyer in Q3 2013 was North Tide Capital, an estimated $5.61M added.
  • The largest Syneron Medical Ltd seller in Q3 2013 was Paradigm Capital Management Inc, an estimated $3.6M sold.

Based on aggregated 13F filings for Q3 2013.